Skip to main content
. 2011 Jun 7;152(8):3172–3181. doi: 10.1210/en.2010-1001

Fig. 3.

Fig. 3.

Ovarian hormone replacement is essential for lordosis and SB enhancement of LQ (mean ± sem). The LQ in females treated with SB in their drinking water and either hormone primed for trials 1–5 (EB + P + SB) and injected with vehicle on trial 6 (G1, n = 5) or injected with vehicle for trials 1–5 (V + SB) and hormone primed only on trial 6 (G2, n = 5) is shown. Box around trial 6 in A indicates the hormone treatment shift. A, LQ data are given over all trials. Inline graphic, EB + P + SB in trials 1–5 and no hormone in trial 6 (G1); Inline graphic, V + SB trials 1–5 and hormone for trial 6 (G2). B, The LQ in trials 5 and 6 (black histogram, EB+P; white histogram, vehicle) are presented. *, Significantly different from own trial 1 baseline (P < 0.05); #, significantly higher than all the other values (P = 0.05).